another interesting piece I found.....
In the end, the primary concern of women interested in avoiding masculinization should not solely be how androgenic a steroid is per mg. Rather, what we need to know is the myotropic ability of a steroid in relation to its androgenic potency, which will then inform us of the steroid’s androgenic pay-load per effective dose. The lower the androgenic pay-load delivered per effective dose, the lower the incidence of androgenic side effects experienced in the user.
Let’s look at some real-world experience for a minute. I will make my point by comparing SD to Anavar, which is FBB’ings most popular steroid for those interested in avoiding androgenic side effects. The typical starting dose for Anavar is between 5-10 mg/day. While most females will experience considerable progress as 1st time users at that dosing amount, there is no denying that several other oral AAS exceed Anavar’s muscle-building potential at an equal dose. With this being the case, would it not be advantageous if we had at our disposal another steroid which supplied an equal or lesser androgenic effect, while surpassing Anavar’s muscle-building potential at the same time? Of course it would and in reality, we do. It’s called SD.
In briefly referring back to the androgenic ratings of these 2 drugs, you will recall that SD has an androgenic rating of 40 (40% as androgenic as testosterone per mg), while Anavar’s is around 25 (25% as androgenic as testosterone per mg). That is only a 15 point discrepancy. 10 mg of Anavar will supply the androgenic equivalent of 2.5 mg of testosterone, while 5 mg of SD will provide the androgenic equivalent of only 2 mg of testosterone. Obviously, 5 mg of SD supplies a weaker androgenic effect than 10 mg of Anavar and therefore a reduced likelihood of experiencing masculinization, so the final question which needs to be asked is “How does 5 mg of SD compare to 10 mg of Anavar in terms of muscle building potential?” The answer: It’s not even close. SD is one of the most potent muscle-builders worldwide. Very few steroids sold today, whether on the black-market, prescription, or OTC, surpass this drug’s ability to add muscle tissue per effective dose. In contrast, Anavar is known as one of the weakest steroids when it comes to muscle growth. In terms of real-world results, SD kicks its ass all over the place, as it does to almost all other steroids.
My dosing recommendations for 1st time users and/or those wishing to minimize masculinization is 2.5-5.0 mg/day. Below I provide an androgenic reference chart, so that females at more advanced levels can make informed decisions regarding their use.
SD @ 2.5 mg/day= 1 mg of Testosterone per day.
SD @ 5.0 mg/day= 2 mg of Testosterone per day.
SD @ 10 mg/day= 4 mg of Testosterone per day.
SD @ 15 mg/day= 6 mg of Testosterone per day.
SD @ 20 mg/day= 8 mg of Testosterone per day.
SD @ 25 mg/day= 10 mg of Testosterone per day.
SD @ 30 mg/day= 12 mg of Testosterone per day.
Lastly, this entire conversation would be rendered near useless if we did not address the topic of hair-loss, as this is typically one of the primary areas of concern for most women wishing to avoid masculinization. Because a steroid’s androgenic rating does not always correlate with its propensity to initiate hair-loss, we must evaluate each steroid individually when determining how likely it is to affect the user in this respect. It should also be noted that the overwhelming majority of anecdotal evidence has been obtained from men.
In the real-world, user experience has shown SD to be a very mild steroid on the hair line, although hair-loss remains a possibility with any steroid. Only a very small minority of people report hair-loss with this drug and when taking into consideration how it fares against other commonly used AAS, I would tend to define it as one of the “least likely” steroids to cause this effect.
I strongly advise that females not familiar with this drug take the time to research it more thoroughly prior to use. This article was not intended to serve as a “profile” for SD, but rather, to help serve as an educational piece regarding this drug’s propensity to cause masculinizing side effects at effective doses and how it applies to females.